CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

SEC filing

CLOVER HEALTH INVESTMENTS, CORP. /DE

CLOV · CIK 1801170

4 · Oct 19, 2026 · CEO, Counterpart Health Wai Conrad sold 23.63K Class A Common Stock at $4.68/unit ($110.6K)

CEO, Counterpart Health Wai Conrad sold 23.63K Class A Common Stock at $4.68/unit ($110.6K)

FORM 4

xslF345X06/wk-form4_1792441323.xmlSEC.gov

Graphics and non-inline formats (not embedded below).